Expectorant Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Expectorant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Granules | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 213420-001 | May 8, 2020 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Marksans Pharma | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 217780-001 | Aug 21, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Aurobindo Pharma | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 210453-002 | Oct 21, 2019 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ohm Labs Inc | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209254-002 | Jul 16, 2018 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Aurobindo Pharma | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 210453-001 | Oct 21, 2019 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
